cholesterol

One-time CRISPR gene therapy cuts cholesterol ~50% for a full year, trial finds

A single infusion of a CRISPR-based gene-editing therapy produced durable reductions in LDL cholesterol and triglycerides that persisted through one year of follow-up, researchers reported Friday at the European Society of Cardiology Congress 2026 in a presentation simultaneously published in…

You're all caught up

You've seen all the main stories from the past 2 days.